CBD Guides

CBN vs CBD: which cannabinoid actually suits your goal?

By the Honest CBD Co team · 25th August 2026

For broad anxiety, pain and most sleep concerns, CBD remains the better-studied option. CBN is less researched but shows genuine promise for reducing night-time awakenings at a specific dose. CBD is non-intoxicating and has decades of research behind it, whereas a recent randomised, placebo-controlled trial found that 20 mg of CBN reduced night-time awakenings without causing next-day grogginess.

CBD: better evidence base, non-intoxicating, useful for anxiety and pain.
CBN: promising but thin evidence, best matched to specific sleep disruption.

Quick stat: in that 2024 trial, 20 mg of nightly CBN cut awakenings with statistical significance (p = .025), though the primary sleep-quality score fell just short of significance.

Keep reading for the mechanisms, the safety caveats, and how to choose a starting dose. We’ll also point you towards the evidence and safety sections if you want the full picture before buying anything.

Key Takeaways

CBD has the deeper, better-established evidence base, while CBN shows a specific, dose-dependent benefit for night-time awakenings that still needs more research to confirm.

Point	Details
CBD suits broader goals	Better evidence for anxiety, pain, and general use; non-intoxicating at all studied doses.
CBN suits specific sleep issues	The 2024 RCT found 20mg nightly CBN reduced awakenings without next-day fatigue.
Dose gap matters	Many retail CBN products sit well below the 20mg dose used in trials.
Check medication interactions	Both cannabinoids can interact with drugs via CYP450 liver enzymes; consult a clinician if unsure.
Honest CBD Co offers a trusted CBD route	UK-made, small-batch oils, capsules and pastes, CBD lab-tested at source, from a family business trading since 2018.

Primary sources and further reading

This article is general information, not a substitute for advice from a qualified doctor. Consult a qualified healthcare professional about your own circumstances before acting on anything here.

What is CBD and how does it work?
What is CBN, and why is research so limited?
CBN vs CBD: how do they actually compare?
What does the strongest clinical evidence actually show?
What are the safety risks and drug interactions?
How do you try CBD or CBN safely?
Our honest view on the CBD vs CBN debate
Ready to try CBD? Here’s where to start
Sources

What is CBD and how does it work?

CBD, or cannabidiol, is a non-intoxicating compound extracted from hemp. It won’t get you high, and it doesn’t attach directly to the receptors that cause a cannabis “buzz”. Instead, CBD works indirectly on the endocannabinoid system, nudging receptor activity rather than switching it on outright.

The strongest evidence sits behind seizure treatment: certain CBD formulations carry regulatory approval for specific epilepsy disorders. Evidence for anxiety and sleep is more mixed, with some health agency summaries noting that outcomes vary depending on the condition and dose used.

Available as oils, capsules, pastes, and topicals.
Retail doses typically range from 10mg to 50mg per serving.
Research doses for anxiety trials often run higher than what’s sold on shelves.

What is CBN, and why is research so limited?

CBN, or cannabinol, isn’t present in meaningful amounts in a fresh cannabis plant. It forms when THC oxidises, usually as cannabis ages or is exposed to light and air. That’s why CBN has a reputation as the cannabinoid found in “old weed”, though the CBN sold today is deliberately produced rather than left to chance.

Pharmacologically, CBN behaves differently to CBD. It’s a partial CB1 receptor agonist, which puts it closer to THC’s mechanism, though most reports describe minimal intoxication even at higher doses. Because CBN forms through degradation rather than direct extraction, isolating it in bulk is harder and more expensive, and that scarcity has kept clinical trials scarce too.

CBN forms via oxidation of THC over time or through controlled processing.
It shows partial CB1 activity but is not considered meaningfully intoxicating in most reports.
Higher production cost means fewer large-scale trials and shorter track record.

Pro Tip: If a product markets CBN purely on “ancient sleep science”, treat that claim sceptically. Robust trial data on CBN is very recent, not centuries old.

CBN vs CBD: how do they actually compare?

The clearest difference is psychoactivity. CBD produces no intoxicating effect at any studied dose. CBN, being a partial CB1 agonist, carries a small theoretical psychoactive potential at higher doses, though most users report nothing resembling a THC high.

Subjectively, CBD tends to feel calming without sedation for most people, while CBN is marketed specifically for sleepiness. That’s reflected in formulation: CBN products are almost always sold as night-time blends, whereas CBD spans daytime and night-time use.

Availability skews heavily towards CBD. It’s cheaper to produce, sold in higher concentrations, and stocked far more widely. CBN costs more per milligram because of its scarcity, and many products contain doses well below the 20mg used in recent sleep trials, which limits how comparable your bottle is to what was actually tested.

For anxiety or pain: CBD has the broader evidence base and larger dose range to work with.
For occasional wakefulness at night: CBN, at doses closer to 20mg, has trial-backed potential; our CBD for sleep guide covers the better-evidenced CBD route.
For daytime use: CBD is the safer, non-intoxicating default; check out our guide to non-drowsy CBD formulations if that’s your priority.

What does the strongest clinical evidence actually show?

The best CBN evidence to date comes from a 2024 double-blind, randomised, placebo-controlled trial. Participants taking 20mg of CBN nightly had significantly fewer awakenings (p = .025) and less overall sleep disturbance (p = .023) than those on placebo, with no rise in next-day fatigue. The primary sleep-quality score improved but didn’t reach statistical significance (p = .082), which means the headline result is encouraging rather than conclusive.

That trial is an outlier in an otherwise thin field. A narrative review that screened 99 human studies found only eight with usable full-text data on CBN, concluding that the evidence remains dated and insufficient to support broad sleep claims.

CBD’s evidence base is deeper but uneven too, strongest for seizure disorders and considerably murkier for sleep, where results vary by dose, formulation and study design.

What are the safety risks and drug interactions?

CBD’s side-effect profile is well documented: digestive upset, dry mouth, and mild drowsiness are the most commonly reported issues. CBN’s safety data is thinner, though the 2024 trial reported no serious adverse events at 20mg over the study period.

Both cannabinoids can interact with medicines processed by CYP450 liver enzymes, the same pathway used by many prescription drugs, including some blood thinners and antidepressants. If you’re on regular medication, that’s a conversation worth having with your GP or pharmacist before starting either compound, and our piece on CBD and ibuprofen interactions is a useful starting point.

Start with a low dose and monitor for digestive or drowsiness effects.
Check any current prescriptions for CYP450 interactions before combining.
Avoid both CBD and CBN during pregnancy or breastfeeding.

Pro Tip: Nightly CBN looks safe over the short study period tested, but no trial has run long enough to confirm safety over months of continuous use. Treat it as a short-term trial, not an indefinite routine.

How do you try CBD or CBN safely?

Pick your form. Oils allow precise titration; capsules suit convenience; gummies and topicals suit specific goals like sleep or localised discomfort.
Start low. Begin with a modest CBD dose and increase gradually; CBN sleep trials used 20mg, so treat that as a reference point, not a starting dose.
Know what is in the bottle. The label should state the CBD in milligrams and the THC position plainly, and a good seller will show you the lab data behind it if you ask. Ours is available on request.
Track your results. Give sleep products several nights to show an effect, and speak to a clinician if you’re on regular medication.

Pro Tip: Timing matters as much as dose. Our guide on the best time to take CBD covers routines for sleep, anxiety, and focus.

Our honest view on the CBD vs CBN debate

We’d rather point you towards the strongest evidence than the loudest marketing claim, which is why the 2024 CBN trial gets so much attention here: it’s a genuine step forward, not proof that CBN belongs in every night-time routine. Every product we make is small-batch and UK-produced, with the CBD lab-tested at source, which is the standard we think this category needs more of. That commitment sits behind our Excellent Trustpilot rating across more than 700 reviews, and it is the same standard we would want applied to any brand making sleep or anxiety claims.

Richard

Ready to try CBD? Here’s where to start

If the evidence has you leaning towards CBD rather than CBN, Honest CBD Co makes that easier than piecing together an unfamiliar routine from scratch. Everything we sell is UK-made in small batches with the exact CBD content in milligrams on the label, and the CBD is lab-tested at source, so you are not guessing at what is in the bottle or how it compares to the doses discussed above.

If you want to titrate slowly and find your own effective dose, our CBD oils let you adjust drop by drop. Prefer something pre-measured for a consistent nightly routine? Our CBD capsules take the guesswork out of dosing entirely, and for those wanting a stronger daily dose, our CBD pastes offer higher concentrations per serving. The capsules come in 40mg, 80mg and 120mg strengths from £19.99, which sits usefully either side of the 20mg reference dose discussed above. If you would rather browse everything at once, our full shop lays out the range, and we are rated Excellent on Trustpilot across more than 700 reviews.